Click any tag below to further narrow down your results
Links
Nvidia Corp. will invest $1 billion over five years to establish a new artificial intelligence laboratory in collaboration with Eli Lilly & Co. The facility, located in Silicon Valley, aims to accelerate the application of AI in the pharmaceutical industry by leveraging Lilly's lab expertise.
Eli Lilly has partnered with Nvidia to develop a powerful supercomputer aimed at accelerating drug discovery. The supercomputer will leverage AI capabilities to identify new molecules and reduce the lengthy drug development process, all while running on renewable energy within Lilly's facilities.